Vigil Neuroscience
Price & Volume
Stats
See more52W Range | $1.49-$6.06 |
Market Cap | $74.8M |
Shares Short | 681,391 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.07 |
News
See moreYahoo Finance • last year
Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference
Yahoo Finance • last year
Vigil Neuroscience Reports Positive Interim Data from Phase 2 IGNITE Proof-of-Concept Clinical Trial Evaluating Iluzanebart (VGL101) as a Treatment for ALSP and from Ongoing Natural History Study ILLUMINATE
Yahoo Finance • last year
Vigil Neuroscience Reports Third Quarter 2023 Financial Results and Provides Business Update
About
CEO | Dr. Ivana Magovcevic-Liebisch J.D., Ph.D. |
Address | 100 Forge Road, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 64 |
